Fluorodopa (18F), AAV2-GDNF, Carbidopa clinical trials

(ASK-PD0-CS002) Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants with Parkinson’s Disease or Multiple System Atrophy

This study is checking on people who previously received a special gene therapy (AAV2-GDNF) for Parkinson's disease or Multiple System Atrophy. It aims to understand how safe and effective the treatment has been for them over a long time, looking at any side effects and how their symptoms are managed.